This inventor holds 2 USPTO granted patents. Top assignee: Hypoxi Co., Ltd.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Innovations by Jongwon Lee in Cell Culture and Ischemia Treatment
Introduction
Jongwon Lee is a notable inventor based in Taegu, South Korea. He has made significant contributions to the field of cell culture and therapeutic agents for ischemic conditions. With a total of 2 patents, his work focuses on enhancing cell survival and viability under challenging conditions.
Latest Patents
One of Jongwon Lee's latest patents is a method for increasing the survival rate of cells in animal cell culture under hypoxia conditions. This innovative method involves adding antibiotics to the culture media, specifically antibacterial agents such as quinolones, quinones, aminoglycosides, or chloramphenicol at concentrations ranging from 0.1 to 1000 µg/ml. This technique can be effectively applied for high-density animal cell culture, particularly for the production of recombinant proteins or cultured cells.
Another significant patent by Jongwon Lee is a therapeutic agent for ischemia that inhibits apoptosis under ischemic conditions. This therapeutic agent also comprises antibacterial agents like quinolones, quinones, aminoglycosides, or chloramphenicol as active ingredients. The invention has shown promise in improving cell viability under hypoxic and hypoglycemic conditions, making it a potential drug for ischemia-associated infarction and cerebral infarction.
Career Highlights
Jongwon Lee is currently associated with Hypoxi Co., Ltd., where he continues to innovate in the field of cell culture and therapeutic solutions. His work has the potential to impact various medical applications, particularly in treating ischemic diseases.
Collaborations
Jongwon Lee collaborates with notable colleagues, including Kyu-Won Kim and Jong-Kyun Lee, contributing to advancements in their respective fields.
Conclusion
Jongwon Lee's innovative patents and contributions to cell culture and ischemia treatment highlight his role as a significant inventor in the scientific community. His work not only enhances our understanding of cell viability but also opens new avenues for therapeutic interventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile